The Hydropothecary Corporation
How Did Cannabis Stocks Perform Last Week?
Tilray (TLRY) stock fell as much as 5.5% last week, while Supreme Cannabis (SPRWF) fell ~4.4% in the week ending May 3.
How Valuation Multiples Stack Up for HEXO, CTST, IIPR, and Peers
As of March 22, the median forward EV-to-sales multiple of cannabis players was 7.0x.
HEXO’s Results Weighed Down Cannabis Sector Last Week
Weakness in the cannabis sector continued last week, especially after HEXO (HEXO) reported its earnings on June 12. HEXO’s earnings largely disappointed the market, and the stock plunged almost 16% in the following days. HEXO’s YTD returns stood at 59% as of June 14 despite the sell-off after its earnings.
ACB, APHA, CTST, and HEXO Fall on March 20
The Horizons Marijuana Life Sciences ETF (HMMJ) had fallen by about 1.2% as of noon on March 20, while the ETFMG Alternative Harvest ETF (MJ) had declined by nearly 0.8%.
Aurora Cannabis: Analysts’ Projections
Analysts expect Aurora Cannabis to report a gross income of 177 million Canadian dollars in 2019 and 508 million Canadian dollars in 2020.
March Valuation Update for CTST, HEXO, KSHB, and Others
In this article, we’ll discuss valuation multiple updates for other cannabis stocks that have gained investors’ attention lately.
Canaccord Genuity Raises Price Target for Canopy Growth
On February 18, Canopy Growth (WEED) received a price target upgrade from Canaccord Genuity.
Top Developments in the Cannabis Industry’s Early Years
In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.
Aurora Cannabis’s Revenue: Here’s What Analysts Expect
Aurora Cannabis is set to release its fiscal 2020 first-quarter earnings results on November 11. Let’s see what analysts expect for its upcoming quarter.
Aurora Cannabis’s Price Target Cut by 30%
Aurora Cannabis (ACB) stock is currently down 29.23% on the NYSE on a YTD (year-to-date) basis. The company has lost 14.81% of its value since October 1.
APHA, CTST, KSHB, and HEXO Gain to Break Their Losing Streaks
Cannabis stocks have recently experienced weakness amid concerns surrounding a global slowdown and companies missing their earnings expectations.
Cannabis Investment: How to Buy ACB, CGC, and Other Stocks
Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds.
HEXO: Analysts’ Target Price and Ratings
CIBC downgraded HEXO to “neutral” from “outperform” and reduced the target price to 8.5 Canadian dollars from 9.5 Canadian dollars.
What Do Analysts Recommend for Canopy Growth?
On December 16, Canopy Growth was trading at 26.79 Canadian dollars, implying a rise of 9.6% since its fiscal 2020 second-quarter earnings release.
Comparing the Valuation Multiples of Cannabis Stocks
In this part of our cannabis valuation series, we’ll discuss the multiples of the remaining cannabis stocks and compare them to the peer (MJ) median of 24x.
Cronos Group Joins Altria to Bet on Cannabidiol Market
Cannabis company Cronos Group has expanded its presence in the US cannabidiol market through a tie-up with tobacco company Altria Group.
Why Canopy Growth Isn’t Happy with Apple
Apple removed 181 vaping-related apps due to the vape crisis in the US. Canopy Growth is not happy with Apple’s move. Let’s see why.
South Dakota Plans for Marijuana Legalization amid COVID-19
Marijuana is illegal in South Dakota. However, the state decided to make both recreational and medical marijuana legal this year.
Why Medical Cannabis Lacks Scientific History
Legal cannabis for medical purposes has been available for several years, yet you’ll often hear people say that cannabis lacks science.
Cannabis Stocks Continue to Struggle on the Last Day of April
The cannabis sector has continued to struggle on the last day of April, and it may very well end up in negative territory.
Medical Cannabis in Brazil Is Coming
According to a Reuters report on December 3, Brazil is ready to approve medical cannabis products. Currently, cannabis is illegal in Brazil.
Marijuana: Will Trump Have an Edge over Biden?
With Biden strongly opposing full-scale legalization, President Trump could turn around things. President Trump might support medical marijuana legalization.
CTST, HEXO, and APHA: Cannabis Stocks Fall on April 9
Overall, the cannabis sector fell on April 9. The Horizon Marijuana Life Sciences ETF (HMMJ) lost almost 2.5% of its value by mid-day.
Most Cannabis Companies Expected to Report Losses for the Quarter
Aurora Cannabis is estimated to report a loss per share of 0.07 Canadian dollars, which would be lower than the profit per share of 0.01 Canadian dollars in the corresponding quarter in 2017.
Aphria: Why Jefferies Recommends a ‘Buy’
Aphria (APHA) reported its results for the first quarter of fiscal 2020 on October 15. Since then, the stock has fallen 7%.
Canopy Gets Estimates Revised by Analysts for 2020
Canopy Growth (CGC) (WEED) missed analysts’ estimates this year. Analysts had huge expectations from CGC after Canada allowed cannabis in 2018.
Cannabis 3.0: Is It on the Horizon?
On October 17, Cannabis 2.0 legalized edibles, beverages, and concentrates in Canada. As the country waits for the benefits, is Cannabis 3.0 next?
Valuation for Cannabis Stocks in October
The cannabis industry is fighting against the ongoing US-China trade war and recessionary worries, which have hurt valuations across the global market.
Canopy Growth: Why PI Financial Suggests a ‘Sell’
Canopy Growth dragged its stock down after its unimpressive end to fiscal 2020. The company missed the revenue estimates by a huge margin.
Will Santa Claus Rally Boost Cannabis Stocks?
On December 26, a Santa Claus rally seems to be in full swing. This effect pushed the S&P 500 (SPX) and Nasdaq Composite Index (COMP) to record highs.
Marijuana: Why Is Washington Changing Its Laws?
In 2012, Washington was the second state to legalize recreational marijuana. Now, the state plans to revamp its marijuana laws.
Marijuana in Texas: Five Things You Should Know
Marijuana laws are pretty strict in Texas, but could this change? Here are five things you need to know about the state’s relationship with marijuana.
Cannabis Beverages: Why Canadians Can’t Wait
Deloitte estimates that the newly legalized cannabis beverage market could be worth 529 million Canadian dollars annually in Canada.
Why Does Jim Cramer Prefer CGC versus CRON?
Canopy Growth (NYSE:CGC) lost 25.4% in 2019. The company reported weak sales and higher-than-expected operating losses in the last two quarters.
No Cannabis Edibles in Three Provinces for Christmas
After Canada legalized cannabis edibles in October, consumers hoped to buy these products this month. However, three provinces must wait until January.
Cannabis 2.0: Aurora Cannabis Gears Up for Edibles Market
Cannabis 2.0 legalization will take place in Canada next month. Cannabis players are gearing up to expand in the edibles market.
Why Auxly Cannabis Group Stock Grew ~6.75% on January 25
On January 25, on the OTC markets, Auxly Cannabis Group’s stock price closed at $0.72, which is ~6.75% higher than its close of $0.67 on January 24 and reflects ~8% growth YTD (year-to-date).
Why Cannabis Stocks Are on the Rise
The reason cannabis stocks are rising could be because October 17 is approaching.
Was CGC a Big Mistake for Constellation Brands?
Canopy Growth (CGC) has seen dizzying ups and gloomy downs in 2019. The stock jumped up by 79.91% from $28.92 on January 2 to $52.03 on April 29.
Michigan Votes in Favor of Legalizing Recreational Marijuana
On November 7, Michigan voted in favor of legalizing recreational marijuana.
Why Aurora Cannabis Wants to Grow Cannabis Outdoors
Aurora Cannabis (ACB) wants to grow cannabis outdoors. In July, it received Health Canada licenses for outdoor cultivation at two Canadian sites.
Cannabis Stocks Up, Broader Equity Market Falls
Today, cannabis stocks are trading in the green despite the weakness in the broader market. The ETFMG Alternative Harvest ETF was up 2.5% as of 2:00 PM ET.
What’s Canopy Growth Strategy for Growth?
Canopy Growth has struggled this year. Despite all their strategies, cannabis companies have failed to hit revenue and profitability targets this year.
IIPR, CRON, TLRY Surging: A Good Day for Cannabis Stocks
It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.
Why Canopy Growth’s Losses Widened in the Second Quarter
During the second quarter, Canopy Growth’s (WEED) (CGC) operating losses widened from ~$1 million to almost $214 million.
Why OrganiGram Is Attracting So Much Attention
OrganiGram (OGRMF) has been in the news lately for several reasons. The company is now covered by investment firm Jefferies, which gave the stock a “buy” recommendation along with Aurora Cannabis (ACB).
Arizona’s Marijuana Campaign Qualifies for November Ballot
Marijuana campaigns in most US states faced challenges gathering enough signatures amid the pandemic. However, Arizona got plenty of signatures.
Marijuana Legalization: What’s Happening in Utah?
Recreational cannabis isn’t legal in Utah. Although the state legalized medical cannabis in 2018, the medical marijuana program will go live in March 2020.
Has Irwin Simon Really Turned Aphria Around?
Aphria (APHA) has impressed investors with its earnings results this year. Overall, the cannabis industry has struggled due to various headwinds.
Do Republicans Want to Join the Cannabis Action?
Republicans have been conservative about cannabis. However, cannabis legalization is a popular discussion topic among Democrats.
Canopy Growth and Cronos Group’s Earnings Next Week
Canopy Growth (CGC) (WEED) and Cronos Group (CRON) are set to release their earnings next week. The cannabis sector has been on a roller coaster this year.
New Year Will Bring Legal Marijuana to Illinois Residents
Marijuana products are top-rated among Americans. Illinois will see recreational marijuana products for sale on January 1.
What Analysts Recommend for CannTrust in February
In February, analysts’ consensus recommendation for CannTrust was a “buy.”
Marijuana: Why Did Mexico Delay Legalization?
Mexico has delayed marijuana legalization. The Supreme Court’s deadline for legalization was October 23. The delay could stretch into November.
Raymond James Foresees a Cannabis Rebound in 2020
Cannabis stocks had a difficult 2019. Besides cannabis companies losing out on revenue and profitability, many external factors also affected the sector. While pessimism drove the industry this year, a Raymond James analyst predicts things can turn around in 2020. Let’s take a look. Raymond James feels the cannabis sector could rebound On December 16, […]
The Market Is Sinking and Taking the Cannabis Sector Along
This morning turned brutal for the overall market with the S&P 500 Index sinking as much as 2.34% through the first half of the day on the back of the trade dispute between the United States and China.
Aurora Cannabis: What’s the Word on the Street?
Aurora Cannabis stock got a boost at the beginning of the month. The company updated its guidance for the fourth quarter.
New Gallup Poll on Marijuana Legalization Support
A recent Gallup poll data found that nearly 66% of Americans support making cannabis legal. However, this figure was the same as in 2018. This suggests a standstill in the rise in support of cannabis legalization. Moreover, nine states will be voting in 2020 on measures to allow cannabis for recreational or medical use. The […]
Assessing Curaleaf Holdings’ Major Developments Year-to-Date
Curaleaf Holdings (LDVTF) has entered into a few agreements for the expansion of its presence, and it’s also achieved a few milestones this year.
Analysts Neutral on Aphria’s 2020 Outlook in December
Aphria has successfully impressed investors compared to other cannabis companies this year, even though the same factors have affected the entire industry.
Cannabis Stocks’ EV-to-EBITDA Multiples on October 23
All nine cannabis stocks experienced a decline in the forward EV-to-EBITDA multiple as of October 23—compared to October 9.
Tilray Expands in Latin America
On October 9, Tilray (TLRY) announced that it completed the acquisition of a distribution company in Latin America, which it says will help the company produce and market medical cannabis-based products in Chile and the rest of Latin America.
Cannabis Stocks’ Valuation Multiples in October: A Comparison
Tilray’s (TLRY) multiple was 536.4x, a month-over-month increase of 88% from 284.9x.
Cannabis Stocks: What Happens in a Recession?
As market analysts increasingly predict an upcoming global recession, we take a look at the impact of a recession on cannabis stocks.
Marijuana Legalization in South Dakota Lies with Voters Now
Marijuana legalization in South Dakota could see daylight in 2020. The state passed measures to legalize both recreational and medical marijuana.
Know the Pros and Cons of Cannabis Edibles
Deloitte says that the Canadian edibles market could reach 2.7 billion Canadian dollars per year. Cannabis 2.0 could help cannabis stocks recover.
Cannabis: Will Top Companies’ Earnings Be a Relief?
The cannabis earnings season has started again. Earnings season is an exciting time for investors who have been eyeing the sector.
Must-Know: Is Canopy Growth Still a Buy?
For fiscal 2020, analysts expect Canopy Growth to report revenues of 404.5 million Canadian dollars—a rise of 78.7% from fiscal 2019.
Coronavirus Revealed Cannabis Supply Chain’s Pitfalls
The cannabis industry has manufacturing operations in China. The coronavirus outbreak revealed some of the pitfalls in the marijuana supply chain.
Regulators Beware: Cannabis Linked to Job Loss
Cannabis is slowly picking up steam again, with more states are pushing to legalize. However, it appears the challenges never end in the marijuana sector.
Cannabis Investing in 2019: A Year of Big Reversals
The cannabis sector has seen a bit of a Jekyll and Hyde situation in 2019. In the first half, cannabis ETFs rose, but in the second half, they plummeted.
Curaleaf Stock: Latest Updates for Investors
Lately, Curaleaf (CURLF) stock received some attention from cannabis investors. The company announced the acquisition of GR Companies on July 17. The acquisition would make Curaleaf one of the biggest cannabis companies. To learn more, read Curaleaf Will Soon Be the World’s Largest Cannabis Company. After the announcement, Curaleaf stock closed almost 17% higher at […]
Valuations: Cannabis Companies Got Battered
CannTrust, Supreme Cannabis, HEXO, and Aphria were trading at a discount to their levels in November. Cannabis stocks have gotten cheaper.
OrganiGram Was the Biggest Cannabis Gainer Last Week
Cannabis sector Overall, the cannabis sector broadly ended in the positive territory for the week ending March 1—compared to the closing on February 22. The Horizons Marijuana Life Sciences ETF (HMMJ) rose nearly 4.6%, while the ETFMG Alternative Harvest ETF (MJ) rose ~1.6%. Let’s look at how some of the major cannabis stocks performed last week. […]
Organigram Has Analysts Confident ahead of Q1 Earnings
Organigram is set to report its fiscal 2020 first-quarter earnings on January 14. The company’s fiscal 2019 fourth-quarter results were stable.
Are Cannabis Edibles Coming to Maryland Soon?
Recreational cannabis isn’t legal in Maryland, but the state has been trying to launch edibles as part of its medical marijuana program.
Get Real: Breaking Down and Bouncing Back
In this morning’s edition of Get Real, we saw that WeWork’s layoffs are taking a toll. Meanwhile, the cannabis industry could be bouncing back.
Marijuana Legalization Catches Federal Reserve Bank’s Attention
The spotlight is on marijuana legalization as the demand keeps surging. More states have stepped up to legalize either recreational or medical cannabis.
Will Hexo Continue to Struggle in 2020?
For the second quarter of fiscal 2020, analysts expect Hexo’s revenue to grow 25.5% YoY (year-over-year) to 16.8 million Canadian dollars.
Comparing Cannabis Stocks’ Valuation Multiples in November
Aurora Cannabis (ACB) was trading at a multiple of 26.4x, which declined from 34x in October.
Cannabis Corruption in the US: Trouble before Elections?
Cannabis legalization has taken a back seat in the US. Since the last Democratic debate, there hasn’t been much discussion about federal legalization.
Cannabis Stocks in Trouble, PI Financial Cuts Target Price
Cannabis stocks see dark clouds looming. The week ending on October 11 was disastrous for the sector. Hexo stock fell after it withdrew its fiscal 2020 outlook.
Marijuana Sales Soar amid Coronavirus Pandemic
Marijuana stocks are seeing a ray of hope amid the coronavirus pandemic. With self-quarantine and lockdowns in many cities, marijuana sales have risen.
Cannabis Stocks Mixed a Day after Cronos Group’s Earnings
Cronos Group (CRON) reported its earnings yesterday, and the stock sank about 8% after the release.
Constellation Still Believes in Canopy Growth, Should You?
Canopy Growth (NYSE:CGC) has always been a hot cannabis stock. The company’s deal with Constellation Brands (NYSE:STZ) makes the stock even more attractive.
HEXO Enters Israel’s Medical Marijuana Market, Stock Surges over 18%
Today, HEXO announced that it launched its medical marijuana products in Israel. The company signed a two-year agreement with an Israeli cannabis company.
Analyzing the Top 3 CBD Companies to Buy in July
Charlotte’s Web Holdings (NYSEARCA:CWEB) is one of the main players in the CBD business. The company plans to keep expanding in 2020.
Marijuana Legalization Hopes Rise in Nebraska for 2020
Marijuana legalization hopes never really ended in Nebraska. Signature gathering paused in the state amid the pandemic and the lockdown.
Marijuana Legalization Still Has a Chance in Idaho
Marijuana legalization in Idaho had to bear the brunt of the coronavirus pandemic. The lockdown forced the state to suspend its medical marijuana campaign.
Is Aphria or OrganiGram a Better Buy for Investors?
Analysts expect Aphria to report revenues of $631.8 million in the next four quarters. Management will focus on the medical and recreational sectors.
What to Expect from OrganiGram’s Q3 Earnings
OrganiGram will likely report its third-quarter earnings before the market opens on July 21. Overall, there isn’t much hope.
Is Curaleaf a Good Cannabis Pick in 2020?
Curaleaf (OTCMKTS:CURLF) is one of the vertically integrated US cannabis companies. The company has been a top player in the US cannabis space.
Add Cannabis Stock HEXO to Your 2019 Watch List
HEXO When it comes to underdogs among cannabis stocks (HMMJ), HEXO (HEXO) is one that comes to the top of our minds as a stock to watch in 2019. The stock has returned nearly 7.6% in 2018—far better than Aphria (APHA), which lost almost 24% in 2018, and Aurora Cannabis (ACB), which is down nearly […]
Cronos and Altria’s Deal: Does It Make Sense Now?
Cronos Group, one of the more resilient cannabis stocks, hasn’t escaped the gloom in the cannabis sector. It’s down 37.44% year-to-date on the Nasdaq.
Canopy Growth Lays Off More Employees, Latest Strategic Review Round
Canopy Growth laid off an unspecified number of employees on Thursday. So far, the company has laid off 800 employees this year.
What to Expect from Marijuana Stocks in July
OrganiGram will likely report its earnings for the third quarter of fiscal 2020 on July 13. We’ll have to see if marijuana stocks recover in July.
Why Did Raymond James Downgrade OrganiGram?
On Monday, Cantech Letter reported that Raymond James downgraded OrganiGram from an “outperform” rating to a “market perform” rating.
Aurora Cannabis’s Cost-Cutting Measures Made Analysts Bullish
Aurora Cannabis (NYSE:ACB) announced some business transformation plans on June 23. The plans included cost savings and margin improvement.
Aurora Cannabis Announces Job Cuts and Facility Closures
On Tuesday, Aurora Cannabis (NYSE:ACB) provided an update on its business transformation plan, which it announced earlier this year.
Canopy Growth Announces Initiatives to Regain Market Share
In the fourth quarter, Canopy Growth (NYSE:CGC)(TSE:WEED) lost market share due to increased competition in value products.